{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T23:18:36Z","timestamp":1794957516727,"version":"4.9.1"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Heart failure is a common complication after acute myocardial infarction (AMI). However, the prognostic impact of patterns of heart failure management during hospitalization remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This multicenter, retrospective study included 2426 patients with AMI undergoing percutaneous coronary intervention. Patients were categorized into three groups: no intravenous (i.v.) heart failure treatment (patients received neither i.v. diuretics nor inotropes\/vasopressors), diuretics only (diuretics without inotropes\/vasopressors), and inotropes (inotropes\/vasopressors with or without diuretics) groups. The primary endpoints included all-cause death during hospitalization and a composite of all-cause death and heart failure rehospitalization after discharge.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Overall, 646 patients (26.6%) developed in-hospital heart failure. During hospitalization, the mortality rate was higher in the inotropes group (34.9%), followed by the diuretics only group (5.9%) and the no i.v. heart failure treatment group (2.2%) (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20050.001). During a median follow-up of 535 days, 196 (9.7%) patients developed the primary endpoint after discharge. A composite of all-cause death and heart failure rehospitalization occurred in 6.5% of the no i.v. heart failure treatment group, while those in the diuretics group (21.2%) and inotropes group (24.3%) had a similar risk of the primary endpoint.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Heart failure events requiring i.v. treatments during hospitalization were associated with an increased in-hospital mortality, particularly in those treated with inotropes in patients with AMI. Among patients who were discharged alive, however, long-term outcomes did not differ significantly between patients treated with diuretics only and inotropes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mca.0000000000001644","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T09:04:40Z","timestamp":1777539880000},"page":"528-536","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic impact of treatment patterns of in-hospital heart failure on clinical outcomes after myocardial infarction"],"prefix":"10.1097","volume":"37","author":[{"given":"Shogo","family":"Okita","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Chiba University Hospital, Chiba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Chiba University Hospital, Chiba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Yaginuma","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Chiba University Hospital, Chiba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunari","family":"Asada","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Chiba University Hospital, Chiba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Goto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Chiba University Hospital, Chiba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuro","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Eastern Chiba Medical Center, Togane"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Chiba Emergency and Psychiatric Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Eastern Chiba Medical Center, Togane"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Chiba Aoba Municipal Hospital, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Chiba Aoba Municipal Hospital, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Kitahara","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Chiba University Hospital, Chiba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Chiba University Hospital, Chiba"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"R1-20261002","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes.","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"R2-20261002","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jchf.2024.04.025","article-title":"Where are we with treatment and prevention of heart failure in patients post-myocardial infarction?","volume":"12","author":"Carberry","year":"2024","journal-title":"JACC Heart Fail"},{"key":"R3-20261002","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/ehf2.14301","article-title":"Prevalence and prognostic impact of left ventricular systolic dysfunction or pulmonary congestion after acute myocardial infarction.","volume":"10","author":"Hamilton","year":"2023","journal-title":"ESC Heart Fail"},{"key":"R4-20261002","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jchf.2022.02.008","article-title":"Acute decompensated heart failure in the setting of acute coronary syndrome.","volume":"10","author":"Harrington","year":"2022","journal-title":"JACC Heart Fail"},{"key":"R5-20261002","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/eurheartj\/ehae885","article-title":"Incident heart failure and recurrent coronary events following acute myocardial infarction.","volume":"46","author":"Butler","year":"2025","journal-title":"Eur Heart J"},{"key":"R6-20261002","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1253\/circj.CJ-24-0633","article-title":"Pharmacological and device-based intervention for preventing heart failure after acute myocardial infarction \u2013 a clinical review.","volume":"88","author":"Saito","year":"2024","journal-title":"Circ J"},{"key":"R7-20261002","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/ehf2.13144","article-title":"Heart failure after myocardial infarction: Incidence and predictors.","volume":"8","author":"Jenca","year":"2021","journal-title":"ESC Heart Fail"},{"key":"R8-20261002","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jchf.2014.10.007","article-title":"Incidence, temporal trends, and prognostic impact of heart failure complicating acute myocardial infarction. The SWEDEHEART registry (Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies): a study of 199,851 patients admitted with index acute myocardial infarctions, 1996 to 2008.","volume":"3","author":"Desta","year":"2015","journal-title":"JACC Heart Fail"},{"key":"R9-20261002","doi-asserted-by":"crossref","first-page":"e002667","DOI":"10.1161\/JAHA.115.002667","article-title":"Heart failure complicating acute myocardial infarction; burden and timing of occurrence: a nation-wide analysis including 86 771 patients from the Cardiovascular Disease in Norway (CVDNOR) project.","volume":"5","author":"Sulo","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"R10-20261002","doi-asserted-by":"crossref","first-page":"e005277","DOI":"10.1161\/JAHA.116.005277","article-title":"Prognostic impact of in-hospital and postdischarge heart failure in patients with acute myocardial infarction: a nationwide analysis using data from the Cardiovascular Disease in Norway (CVDNOR) project.","volume":"6","author":"Sulo","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"R11-20261002","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1253\/circj.CJ-22-0577","article-title":"Prognostic value of natriuretic peptide levels and in-hospital heart failure events in patients with acute myocardial infarction.","volume":"87","author":"Asada","year":"2023","journal-title":"Circ J"},{"key":"R12-20261002","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure.","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"R13-20261002","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1007\/s12630-022-02337-7","article-title":"Inotropes, vasopressors, and mechanical circulatory support for treatment of cardiogenic shock complicating myocardial infarction: a systematic review and network meta-analysis.","volume":"69","author":"Fernando","year":"2022","journal-title":"Can J Anaesth"},{"key":"R14-20261002","first-page":"1141","article-title":"Identifying patients for safe early hospital discharge following ST-elevation myocardial infarction.","volume":"89","author":"Sharkawi","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"key":"R15-20261002","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1253\/circj.CJ-24-0612","article-title":"Impact of the stress hyperglycemia ratio on heart failure and atherosclerotic cardiovascular events after acute myocardial infarction.","volume":"89","author":"Okita","year":"2025","journal-title":"Circ J"},{"key":"R16-20261002","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jacasi.2024.03.008","article-title":"Impact of cancer, inflammation, and no standard risk factors in patients with myocardial infarction.","volume":"4","author":"Yaginuma","year":"2024","journal-title":"JACC Asia"},{"key":"R17-20261002","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.amjcard.2024.02.007","article-title":"Prognostic impact of previous atherosclerotic cardiovascular disease on short- and long-term outcomes in acute myocardial infarction.","volume":"217","author":"Saito","year":"2024","journal-title":"Am J Cardiol"},{"key":"R18-20261002","doi-asserted-by":"crossref","first-page":"e0289794","DOI":"10.1371\/journal.pone.0289794","article-title":"Clinical characteristics and outcomes of patients with chronic systemic inflammatory disease in acute myocardial infarction.","volume":"18","author":"Yaginuma","year":"2023","journal-title":"PLoS One"},{"key":"R19-20261002","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.5551\/jat.64217","article-title":"Differential impact of clinical factors for predicting high platelet reactivity on clinical outcomes in acute myocardial infarction patients treated with clopidogrel and prasugrel.","volume":"30","author":"Goto","year":"2023","journal-title":"J Atheroscler Thromb"},{"key":"R20-20261002","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.hlc.2022.06.666","article-title":"Clinical characteristics and prognosis of patients with no standard modifiable risk factors in acute myocardial infarction.","volume":"31","author":"Suzuki","year":"2022","journal-title":"Heart Lung Circ"},{"key":"R21-20261002","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1253\/circj.CJ-21-0556","article-title":"Impact of PARIS and CREDO-Kyoto thrombotic and bleeding risk scores on clinical outcomes in patients with acute myocardial infarction.","volume":"86","author":"Yamashita","year":"2022","journal-title":"Circ J"},{"key":"R22-20261002","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.amjcard.2021.08.021","article-title":"Impact of active and historical cancer on short- and long-term outcomes in patients with acute myocardial infarction.","volume":"159","author":"Matsumoto","year":"2021","journal-title":"Am J Cardiol"},{"key":"R23-20261002","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s12928-024-01036-y","article-title":"CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) in 2024.","volume":"39","author":"Ozaki","year":"2024","journal-title":"Cardiovasc Interv Ther"},{"key":"R24-20261002","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s12928-023-00976-1","article-title":"Volume-outcome relationships for extracorporeal membrane oxygenation in acute myocardial infarction.","volume":"39","author":"Saito","year":"2024","journal-title":"Cardiovasc Interv Ther"},{"key":"R25-20261002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12928-023-00957-4","article-title":"CVIT 2023 clinical expert consensus document on intravascular ultrasound.","volume":"39","author":"Saito","year":"2024","journal-title":"Cardiovasc Interv Ther"},{"key":"R26-20261002","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12928-023-00954-7","article-title":"Contemporary coronary drug-eluting and coated stents: an updated mini-review (2023).","volume":"39","author":"Saito","year":"2024","journal-title":"Cardiovasc Interv Ther"},{"key":"R27-20261002","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s12928-022-00907-6","article-title":"Complete revascularization in acute myocardial infarction: a clinical review.","volume":"38","author":"Saito","year":"2023","journal-title":"Cardiovasc Interv Ther"},{"key":"R28-20261002","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1253\/circj.CJ-24-0286","article-title":"Volume-outcome relationships for intra-aortic balloon pump in acute myocardial infarction.","volume":"88","author":"Saito","year":"2024","journal-title":"Circ J"},{"key":"R29-20261002","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1253\/circj.CJ-24-0522","article-title":"Prognostic survey of ECPELLA in Japanese patients with acute myocardial infarction and cardiogenic shock \u2013 findings from the Japanese Registry for Percutaneous Ventricular Assist Device (J-PVAD).","volume":"89","author":"Arai","year":"2025","journal-title":"Circ J"},{"key":"R30-20261002","doi-asserted-by":"crossref","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","article-title":"Fourth universal definition of myocardial infarction (2018).","volume":"138","author":"Thygesen","year":"2018","journal-title":"Circulation"},{"key":"R31-20261002","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0002-9149(67)90023-9","article-title":"Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients.","volume":"20","author":"Killip","year":"1967","journal-title":"Am J Cardiol"},{"key":"R32-20261002","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1253\/circj.CJ-19-0133","article-title":"JCS 2018 guideline on diagnosis and treatment of acute coronary syndrome.","volume":"83","author":"Kimura","year":"2019","journal-title":"Circ J"},{"key":"R33-20261002","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.3390\/jcm13092501","article-title":"Differential prognostic impact of risk-prediction models for heart failure in acute myocardial infarction: the original and revised heart failure time-points.","volume":"13","author":"Asada","year":"2024","journal-title":"J Clin Med"},{"key":"R34-20261002","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1161\/CIRCULATIONAHA.117.029289","article-title":"Standardized end point definitions for coronary intervention trials: the Academic Research Consortium-2 consensus document.","volume":"137","author":"Garcia-Garcia","year":"2018","journal-title":"Circulation"},{"key":"R35-20261002","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/MCA.0000000000000815","article-title":"The effect of complete revascularization in patients with st-segment elevation myocardial infarction with Killip class \u2265 III.","volume":"31","author":"Lee","year":"2020","journal-title":"Coron Artery Dis"},{"key":"R36-20261002","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/ehjcvp\/pvae078","article-title":"Inotropes and mortality in patients with cardiogenic shock: an instrumental variable analysis from the SWEDEHEART registry.","volume":"11","author":"Petursson","year":"2025","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"R37-20261002","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1056\/NEJMoa2312572","article-title":"Microaxial flow pump or standard care in infarct-related cardiogenic shock.","volume":"390","author":"Moller","year":"2024","journal-title":"N Engl J Med"},{"key":"R38-20261002","doi-asserted-by":"crossref","first-page":"e053254","DOI":"10.1136\/bmjopen-2021-053254","article-title":"Current use of inotropes according to initial blood pressure and peripheral perfusion in the treatment of congestive heart failure: findings from a multicentre observational study.","volume":"12","author":"Nagao","year":"2022","journal-title":"BMJ Open"},{"key":"R39-20261002","doi-asserted-by":"crossref","first-page":"101326","DOI":"10.1016\/j.cpcardiol.2022.101326","article-title":"Loop diuretic use is associated with adverse clinical outcomes in acute myocardial infarction patients with low volume status.","volume":"47","author":"Kawai","year":"2022","journal-title":"Curr Probl Cardiol"},{"key":"R40-20261002","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJMoa2104508","article-title":"Angiotensin receptor-neprilysin inhibition in acute myocardial infarction.","volume":"385","author":"Pfeffer","year":"2021","journal-title":"N Engl J Med"},{"key":"R41-20261002","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1056\/NEJMoa2314051","article-title":"Empagliflozin after acute myocardial infarction.","volume":"390","author":"Butler","year":"2024","journal-title":"N Engl J Med"},{"key":"R42-20261002","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1056\/NEJMoa2405923","article-title":"Routine spironolactone in acute myocardial infarction.","volume":"392","author":"Jolly","year":"2025","journal-title":"N Engl J Med"},{"key":"R43-20261002","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jjcc.2022.07.003","article-title":"Treatment strategies of acute myocardial infarction: updates on revascularization, pharmacological therapy, and beyond.","volume":"81","author":"Saito","year":"2023","journal-title":"J Cardiol"},{"key":"R44-20261002","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1253\/circj.CJ-24-0422","article-title":"Characteristics and in-hospital outcomes of patients with myocardial infarction with non-obstructive coronary arteries - Insights from the real-world JAMIR database.","volume":"89","author":"Onuma","year":"2025","journal-title":"Circ J"},{"key":"R45-20261002","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock.","volume":"362","author":"De Backer","year":"2010","journal-title":"N Engl J Med"},{"key":"R46-20261002","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1056\/NEJMoa2026845","article-title":"Milrinone as compared with dobutamine in the treatment of cardiogenic shock.","volume":"385","author":"Mathew","year":"2021","journal-title":"N Engl J Med"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MCA.0000000000001644","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:00:46Z","timestamp":1790949646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MCA.0000000000001644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000001644","relation":{},"ISSN":["0954-6928","1473-5830"],"issn-type":[{"value":"0954-6928","type":"print"},{"value":"1473-5830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]}}}